Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.
Ginestier C, Adélaïde J, Gonçalvès A, Repellini L, Sircoulomb F, Letessier A, Finetti P, Geneix J, Charafe-Jauffret E, Bertucci F, Jacquemier J, Viens P, Birnbaum D. Ginestier C, et al. Among authors: geneix j. Oncogene. 2007 Nov 1;26(50):7163-9. doi: 10.1038/sj.onc.1210528. Epub 2007 May 21. Oncogene. 2007. PMID: 17525746
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.
Letessier A, Garrido-Urbani S, Ginestier C, Fournier G, Esterni B, Monville F, Adélaïde J, Geneix J, Xerri L, Dubreuil P, Viens P, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Lopez M, Chaffanet M. Letessier A, et al. Among authors: geneix j. Oncogene. 2007 Jan 11;26(2):298-307. doi: 10.1038/sj.onc.1209772. Epub 2006 Jul 3. Oncogene. 2007. PMID: 16819513
Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis.
Jacquemier JD, Penault-Llorca FM, Bertucci F, Sun ZZ, Houvenaeghel GF, Geneix JA, Puig BD, Bardou VJ, Hassoun JA, Birnbaum D, Viens PJ. Jacquemier JD, et al. Among authors: geneix ja. J Pathol. 1998 Feb;184(2):130-5. doi: 10.1002/(SICI)1096-9896(199802)184:2<130::AID-PATH19>3.0.CO;2-W. J Pathol. 1998. PMID: 9602702
FGF7 protein expression in human breast carcinomas.
Jacquemier J, Sun ZZ, Penault-Llorca F, Geneix J, Devilard E, Adélaïde J, Birnbaum D. Jacquemier J, et al. Among authors: geneix j. J Pathol. 1998 Nov;186(3):269-74. doi: 10.1002/(SICI)1096-9896(1998110)186:3<269::AID-PATH187>3.0.CO;2-G. J Pathol. 1998. PMID: 10211115
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3.
Jacquemier J, Mathoulin-Portier MP, Valtola R, Charafe-Jauffret E, Geneix J, Houvenaeghel G, Puig B, Bardou VJ, Hassoun J, Viens P, Birnbaum D. Jacquemier J, et al. Among authors: geneix j. Int J Cancer. 2000 Jan 20;89(1):69-73. doi: 10.1002/(sici)1097-0215(20000120)89:1<69::aid-ijc11>3.0.co;2-m. Int J Cancer. 2000. PMID: 10719733 Free article.
Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers.
Jacquemier J, Eisinger F, Noguès C, Sun ZZ, Guinebretière JM, Peyrat JP, Geneix J, Lidereau R, Birnbaum D, Sobol H. Jacquemier J, et al. Among authors: geneix j. Int J Cancer. 1999 Sep 24;83(1):45-9. doi: 10.1002/(sici)1097-0215(19990924)83:1<45::aid-ijc9>3.0.co;2-g. Int J Cancer. 1999. PMID: 10449606 Free article.
27 results